ERG and prostate cancer: However, even after prolonged (8 days) and effective TDRD1 silencing in VCaP cells we observed no significant differences in LINE1 expression (Fig. 5c), indicating that TDRD1 abundance does not control LINE1 activity in TMPRSS2:ERG-positive prostate cancer cells.